Overview
Stryker Corporation, based in the United States, operates primarily in the medical technology industry. Renowned for its innovative products and services, Stryker specializes in a wide range of medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products. Key projects and initiatives typically focus on the development and enhancement of joint replacement systems, surgical equipment, and neurosurgical, neurovascular, and spinal devices. As a global leader in medical technology, Stryker is committed to making healthcare better by providing innovative solutions and services that improve outcomes. The company's dedication to innovation and quality has established its reputation as a pioneer in the medical field, continuously driving advancements in healthcare.
AI+ Ask Fintel’s AI assistant about Stryker Corporation.
Thinking about good questions…
Basic Stats
The share price of Stryker Corporation as of 10 July 2025 is € 339,00 / share. The market cap (or net worth) of Stryker Corporation as of 10 July 2025 is € 129.565,80 MM.
The Factor Analysis chart (below right) shows a view of Stryker Corporation from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 129,565.80 MM |
| EV | |
| Shares Out. | 382.20 MM |
| Earnings Date | |
| EPS (TTM) | 7.49 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-09-30 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.08 |
| Beta | 1.48 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.07 |
| ROE | 0.14 |
| ROIC | 0.07 |
| CROIC | -0.00 |
| OCROIC | 0.11 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | 96.93 /100 |
| Analyst Sentiment | 38.20 /100 |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 5.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Stryker Corporation is € 380,01. The forecasts range from a low of € 273,71 to a high of € 437,42. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Stryker Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-15 | BTIG | Buy | Buy | Maintains |
| 2024-07-15 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-02 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-05-30 | Goldman Sachs | Neutral | Initiate | |
| 2024-05-22 | Needham | Hold | Buy | Upgrade |
| 2024-05-02 | Barclays | Overweight | Overweight | Maintains |
| 2024-05-01 | UBS | Neutral | Neutral | Maintains |
| 2024-05-01 | Roth MKM | Buy | Buy | Maintains |
| 2024-05-01 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-05-01 | Stifel | Buy | Buy | Maintains |
| 2024-05-01 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-05-01 | BTIG | Buy | Buy | Maintains |
| 2024-05-01 | Baird | Outperform | Outperform | Maintains |
| 2024-05-01 | Needham | Hold | Reiterate | |
| 2024-04-15 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-04-11 | TD Cowen | Buy | Buy | Maintains |
| 2024-04-04 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-04-03 | Citigroup | Buy | Buy | Maintains |
| 2024-02-15 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-01-31 | Citigroup | Buy | Buy | Maintains |
| 2024-01-31 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2024-01-31 | Roth MKM | Buy | Buy | Maintains |
| 2024-01-31 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-01-31 | Truist Securities | Hold | Hold | Maintains |
| 2024-01-31 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-01-12 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-12-22 | Truist Securities | Hold | Hold | Maintains |
| 2023-12-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-09 | Roth MKM | Buy | Buy | Reiterate |
| 2023-11-09 | UBS | Neutral | Neutral | Maintains |
| 2023-11-06 | Truist Securities | Hold | Hold | Maintains |
| 2023-10-20 | Roth MKM | Buy | Initiate | |
| 2023-10-02 | Citigroup | Buy | Buy | Maintains |
| 2023-09-05 | B of A Securities | Neutral | Buy | Upgrade |
| 2023-08-17 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-08-07 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-08-07 | Barclays | Overweight | Overweight | Maintains |
| 2023-07-19 | Truist Securities | Hold | Hold | Maintains |
| 2023-07-12 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-06-05 | RBC Capital | Outperform | Reiterate | |
| 2023-05-25 | Argus Research | Buy | Buy | Maintains |
| 2023-05-03 | Citigroup | Buy | Maintains | |
| 2023-05-02 | Deutsche Bank | Hold | Maintains | |
| 2023-05-02 | Stifel | Buy | Maintains | |
| 2023-05-02 | JP Morgan | Overweight | Maintains | |
| 2023-05-02 | Jefferies | Buy | Maintains | |
| 2023-05-02 | BTIG | Buy | Maintains | |
| 2023-05-02 | RBC Capital | Outperform | Maintains | |
| 2023-05-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-05-02 | Canaccord Genuity | Hold | Maintains | |
| 2023-05-02 | Piper Sandler | Overweight | Maintains | |
| 2023-05-02 | Baird | Outperform | Maintains | |
| 2023-05-02 | Wells Fargo | Overweight | Maintains | |
| 2023-05-02 | Barclays | Overweight | Maintains | |
| 2023-04-17 | BTIG | Buy | Maintains | |
| 2023-04-17 | Loop Capital | Buy | Maintains | |
| 2023-04-17 | Truist Securities | Hold | Maintains | |
| 2023-04-03 | Citigroup | Buy | Maintains | |
| 2023-03-31 | Jefferies | Buy | Maintains | |
| 2023-03-29 | UBS | Neutral | Initiate | |
| 2023-03-28 | Canaccord Genuity | Hold | Reiterate | |
| 2023-02-21 | Argus Research | Buy | Maintains | |
| 2023-02-02 | Barclays | Overweight | Maintains | |
| 2023-02-01 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-02-01 | Loop Capital | Buy | Maintains | |
| 2023-02-01 | Wells Fargo | Overweight | Maintains | |
| 2023-02-01 | BTIG | Buy | Maintains | |
| 2023-02-01 | Truist Securities | Hold | Maintains | |
| 2023-02-01 | RBC Capital | Outperform | Maintains | |
| 2023-02-01 | Canaccord Genuity | Hold | Maintains | |
| 2023-02-01 | Baird | Outperform | Maintains | |
| 2023-02-01 | Citigroup | Buy | Maintains | |
| 2023-02-01 | Piper Sandler | Overweight | Maintains | |
| 2023-01-31 | Truist Securities | Hold | Maintains | |
| 2020-04-13 | Raymond James | Outperform | Maintains | |
| 2020-04-13 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2020-04-01 | Wells Fargo | Overweight | Maintains | |
| 2020-04-01 | Goldman Sachs | Buy | Sell | Downgrade |
| 2020-03-27 | Citigroup | Buy | Maintains | |
| 2020-03-27 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-24 | Stifel | Buy | Maintains | |
| 2020-03-06 | Credit Suisse | Outperform | Maintains | |
| 2020-03-05 | Citigroup | Buy | Initiate | |
| 2020-02-13 | Goldman Sachs | Buy | Initiate | |
| 2016-04-11 | Barclays | Underweight | Initiate | |
| 2020-01-29 | Baird | Outperform | Maintains | |
| 2020-01-29 | Stifel Nicolaus | Buy | Maintains | |
| 2020-01-29 | Morgan Stanley | Overweight | Maintains | |
| 2020-01-08 | SunTrust Robinson Humphrey | Hold | Initiate | |
| 2019-12-30 | BTIG | Buy | Maintains | |
| 2019-12-17 | Morgan Stanley | Overweight | Maintains | |
| 2019-11-05 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2019-10-30 | UBS | Neutral | Maintains | |
| 2019-10-30 | Canaccord Genuity | Buy | Maintains | |
| 2019-10-30 | Baird | Outperform | Maintains | |
| 2019-10-30 | Stifel Nicolaus | Buy | Maintains | |
| 2019-07-26 | Baird | Outperform | Maintains | |
| 2019-07-26 | Credit Suisse | Outperform | Maintains | |
| 2019-07-26 | Piper Jaffray | Overweight | Maintains | |
| 2019-07-26 | Cantor Fitzgerald | Neutral | Maintains | |
| 2019-07-26 | Canaccord Genuity | Buy | Maintains | |
| 2019-07-16 | Morgan Stanley | Overweight | Maintains | |
| 2019-07-11 | Credit Suisse | Outperform | Maintains | |
| 2019-07-02 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2019-04-24 | Deutsche Bank | Buy | Buy | Maintains |
| 2019-04-24 | Canaccord Genuity | Buy | Buy | Maintains |
| 2019-04-24 | Baird | Outperform | Outperform | Maintains |
| 2019-04-24 | Cantor Fitzgerald | Neutral | Maintains | |
| 2019-04-15 | Barclays | Overweight | Overweight | Maintains |
| 2019-03-11 | RBC Capital | Outperform | Outperform | Maintains |
| 2019-03-04 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2019-01-03 | Deutsche Bank | Buy | Initiate | |
| 2019-01-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2019-01-02 | Citigroup | Neutral | Neutral | Maintains |
| 2019-01-02 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2018-12-18 | Credit Suisse | Outperform | Initiate | |
| 2018-11-28 | UBS | Neutral | Initiate | |
| 2018-11-15 | Citigroup | Neutral | Neutral | Maintains |
| 2018-10-16 | Barclays | Overweight | Initiate | |
| 2018-08-16 | BTIG Research | Buy | Initiate | |
| 2018-07-25 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2018-07-25 | Citigroup | Neutral | Neutral | Maintains |
| 2018-07-25 | Baird | Outperform | Outperform | Maintains |
| 2018-06-27 | Bernstein | Market Perform | Initiate | |
| 2018-05-01 | Citigroup | Neutral | Neutral | Maintains |
| 2018-04-27 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2018-04-27 | Canaccord Genuity | Buy | Buy | Maintains |
| 2018-04-03 | Evercore ISI Group | In-Line | Initiate | |
| 2018-03-15 | Raymond James | Outperform | Initiate | |
| 2018-02-27 | Citigroup | Sell | Neutral | Upgrade |
| 2018-02-26 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-01-31 | Leerink Swann | Outperform | Outperform | Maintains |
| 2018-01-02 | JP Morgan | Neutral | Overweight | Upgrade |
| 2017-11-16 | Baird | Neutral | Outperform | Upgrade |
| 2017-10-27 | Canaccord Genuity | Buy | Maintains | |
| 2017-10-27 | Stifel Nicolaus | Buy | Maintains | |
| 2017-10-27 | Barclays | Underweight | Maintains | |
| 2017-08-25 | Needham | Underperform | Hold | Upgrade |
| 2017-08-24 | Canaccord Genuity | Buy | Maintains | |
| 2017-06-30 | Cantor Fitzgerald | Neutral | Initiate | |
| 2017-05-16 | Goldman Sachs | Neutral | Initiate | |
| 2016-12-15 | UBS | Neutral | Buy | Upgrade |
| 2016-11-01 | BMO Capital | Underperform | Market Perform | Upgrade |
| 2016-10-14 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2016-06-09 | Guggenheim | Buy | Initiate | |
| 2016-04-27 | Sterne Agee CRT | Neutral | Buy | Upgrade |
| 2016-04-27 | Argus | Buy | Maintains | |
| 2016-04-13 | Baird | Outperform | Neutral | Downgrade |
| 2023-01-25 | Keybanc | Sector Weight | Initiate | |
| 2023-01-09 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2023-01-06 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-12-20 | Truist Securities | Hold | Maintains | |
| 2022-12-12 | Wells Fargo | Overweight | Maintains | |
| 2022-12-02 | Barclays | Overweight | Maintains | |
| 2022-11-01 | RBC Capital | Sector Perform | Maintains | |
| 2022-11-01 | Wells Fargo | Overweight | Maintains | |
| 2022-11-01 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2022-10-18 | Barclays | Overweight | Initiate | |
| 2022-10-17 | BTIG | Buy | Maintains | |
| 2022-10-12 | Jefferies | Buy | Initiate | |
| 2022-09-14 | Piper Sandler | Overweight | Maintains | |
| 2022-09-06 | BTIG | Buy | Maintains | |
| 2022-07-28 | Edward Jones | Hold | Buy | Upgrade |
| 2022-07-27 | Wells Fargo | Overweight | Maintains | |
| 2022-07-27 | RBC Capital | Sector Perform | Maintains | |
| 2022-07-27 | Piper Sandler | Overweight | Maintains | |
| 2022-07-22 | Cowen & Co. | Outperform | Maintains | |
| 2022-07-21 | Deutsche Bank | Buy | Hold | Downgrade |
| 2022-07-18 | BTIG | Buy | Maintains | |
| 2022-07-18 | Stifel | Buy | Maintains | |
| 2022-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-11 | B of A Securities | Buy | Neutral | Downgrade |
| 2022-05-17 | Citigroup | Buy | Maintains | |
| 2022-05-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-04-29 | Piper Sandler | Overweight | Maintains | |
| 2022-04-29 | Wells Fargo | Overweight | Maintains | |
| 2022-04-13 | Truist Securities | Hold | Initiate | |
| 2022-03-16 | Bernstein | Market Perform | Outperform | Upgrade |
| 2022-03-15 | Evercore ISI Group | Outperform | Reiterate | |
| 2022-01-31 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-01-28 | BTIG | Buy | Maintains | |
| 2022-01-28 | SVB Leerink | Outperform | Maintains | |
| 2022-01-07 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2022-01-04 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2021-12-10 | RBC Capital | Sector Perform | Initiate | |
| 2021-12-07 | Loop Capital | Buy | Initiate | |
| 2021-11-19 | Morgan Stanley | Overweight | Maintains | |
| 2021-07-28 | Canaccord Genuity | Buy | Maintains | |
| 2021-07-28 | Northland Capital Markets | Market Perform | Outperform | Upgrade |
| 2021-07-28 | Morgan Stanley | Overweight | Maintains | |
| 2021-07-28 | Credit Suisse | Outperform | Maintains | |
| 2021-07-28 | Oppenheimer | Perform | Maintains | |
| 2021-07-28 | SVB Leerink | Outperform | Maintains | |
| 2021-06-01 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2021-05-25 | Barclays | Underweight | Initiate | |
| 2021-04-28 | Canaccord Genuity | Buy | Maintains | |
| 2021-04-28 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-28 | Wells Fargo | Overweight | Maintains | |
| 2021-04-28 | Raymond James | Outperform | Maintains | |
| 2021-02-24 | JP Morgan | Overweight | Maintains | |
| 2021-01-28 | Credit Suisse | Outperform | Maintains | |
| 2021-01-28 | Morgan Stanley | Overweight | Maintains | |
| 2021-01-28 | Raymond James | Outperform | Maintains | |
| 2021-01-06 | Credit Suisse | Outperform | Maintains | |
| 2020-12-15 | Morgan Stanley | Overweight | Maintains | |
| 2020-10-30 | Canaccord Genuity | Buy | Maintains | |
| 2020-10-30 | SVB Leerink | Outperform | Maintains | |
| 2020-10-30 | Credit Suisse | Outperform | Maintains | |
| 2020-10-12 | Raymond James | Outperform | Maintains | |
| 2020-10-06 | Northland Capital Markets | Market Perform | Initiate | |
| 2020-07-31 | SVB Leerink | Outperform | Maintains | |
| 2020-07-31 | UBS | Neutral | Maintains | |
| 2020-07-31 | Credit Suisse | Outperform | Maintains | |
| 2020-07-31 | Morgan Stanley | Overweight | Maintains | |
| 2020-07-31 | Citigroup | Buy | Maintains | |
| 2020-05-11 | Argus Research | Buy | Maintains | |
| 2020-05-01 | Wells Fargo | Overweight | Maintains | |
| 2020-05-01 | CFRA | Strong Buy | Maintains | |
| 2020-05-01 | Citigroup | Buy | Maintains | |
| 2020-05-01 | Credit Suisse | Outperform | Maintains | |
| 2020-05-01 | Morgan Stanley | Overweight | Maintains | |
| 2020-05-01 | Stifel | Buy | Maintains | |
| 2020-05-01 | UBS | Neutral | Maintains | |
| 2020-04-15 | JP Morgan | Overweight | Maintains | |
| 2020-01-29 | Deutsche Bank | Buy | Maintains | |
| 2016-03-17 | Nomura | Neutral | Initiate | |
| 2016-02-01 | Deutsche Bank | Buy | Maintains | |
| 2016-01-27 | Brean Capital | Hold | Buy | Upgrade |
| 2016-01-07 | Northland Securities | Outperform | Market Perform | Downgrade |
| 2015-12-14 | BMO Capital | Market Perform | Underperform | Downgrade |
| 2015-11-13 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2015-11-12 | Citigroup | Sell | Initiate | |
| 2015-11-04 | Sterne Agee CRT | Neutral | Initiate | |
| 2015-09-28 | Needham | Buy | Hold | Downgrade |
| 2015-08-12 | Stifel Nicolaus | Buy | Maintains | |
| 2015-07-24 | Canaccord Genuity | Buy | Maintains | |
| 2015-04-22 | Deutsche Bank | Buy | Maintains | |
| 2015-04-02 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2015-01-28 | Stifel Nicolaus | Buy | Maintains | |
| 2015-01-28 | Jefferies | Hold | Maintains | |
| 2015-01-27 | Credit Suisse | Outperform | Maintains | |
| 2015-01-05 | JP Morgan | Overweight | Neutral | Downgrade |
| 2014-12-05 | Leerink Swann | Outperform | Maintains | |
| 2014-12-02 | Goldman Sachs | Buy | Conviction Buy | Upgrade |
| 2014-11-24 | JP Morgan | Overweight | Maintains | |
| 2014-10-17 | Canaccord Genuity | Buy | Maintains | |
| 2014-07-21 | Citigroup | Neutral | Maintains | |
| 2014-07-18 | Barclays | Equal-Weight | Maintains | |
| 2014-07-18 | Jefferies | Hold | Maintains | |
| 2014-06-11 | Argus | Hold | Buy | Upgrade |
| 2014-04-24 | Canaccord Genuity | Buy | Maintains | |
| 2014-04-14 | SunTrust Robinson Humphrey | Reduce | Neutral | Upgrade |
| 2014-01-24 | Citigroup | Neutral | Maintains | |
| 2014-01-23 | Morgan Stanley | Overweight | Maintains | |
| 2014-01-23 | Stifel Nicolaus | Buy | Maintains | |
| 2013-11-25 | Bernstein | Market Perform | Outperform | Upgrade |
| 2013-09-06 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2013-08-08 | Needham | Hold | Initiate | |
| 2013-07-19 | Wunderlich | Buy | Hold | Downgrade |
| 2013-04-25 | Wunderlich | Buy | Maintains | |
| 2013-03-04 | Goldman Sachs | Buy | Maintains | |
| 2013-02-07 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2013-02-05 | UBS | Buy | Neutral | Downgrade |
| 2013-01-24 | Morgan Stanley | Overweight | Maintains | |
| 2013-01-24 | BMO Capital | Market Perform | Maintains | |
| 2013-01-24 | Stifel Nicolaus | Buy | Maintains | |
| 2013-01-24 | Jefferies | Hold | Maintains | |
| 2013-01-04 | Deutsche Bank | Buy | Maintains | |
| 2012-12-18 | Standpoint Research | Buy | Hold | Downgrade |
| 2012-12-12 | Bank of America | Buy | Maintains | |
| 2012-12-11 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2012-11-20 | Stifel Nicolaus | Buy | Initiate | |
| 2012-10-18 | JP Morgan | Overweight | Maintains | |
| 2012-10-18 | Jefferies | Hold | Maintains | |
| 2012-10-18 | UBS | Buy | Maintains | |
| 2012-10-18 | Oppenheimer | Outperform | Perform | Downgrade |
| 2012-10-18 | Cantor Fitzgerald | Hold | Maintains | |
| 2012-09-21 | Brean Capital | Hold | Initiate | |
| 2012-09-07 | Cantor Fitzgerald | Hold | Maintains | |
| 2012-08-02 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2012-07-19 | Canaccord Genuity | Buy | Maintains | |
| 2012-07-10 | Citigroup | Neutral | Maintains | |
| 2012-04-18 | Goldman Sachs | Neutral | Maintains | |
| 2012-04-18 | PiperJaffray | Overweight | Maintains | |
| 2012-03-01 | Wells Fargo | Outperform | Initiate | |
| 2024-08-01 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-01 | Truist Securities | Hold | Hold | Maintains |
| 2024-10-31 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-28 | BTIG | Buy | Buy | Maintains |
| 2024-09-10 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-09-10 | Wolfe Research | Outperform | Initiate | |
| 2024-10-01 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-12-12 | Needham | Buy | Buy | Maintains |
| 2024-12-18 | Truist Securities | Hold | Hold | Maintains |
| 2025-01-30 | Truist Securities | Hold | Hold | Maintains |
| 2025-01-30 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-10-31 | Citigroup | Buy | Buy | Maintains |
| 2024-08-01 | Needham | Buy | Buy | Maintains |
| 2024-07-31 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-07-31 | UBS | Neutral | Neutral | Maintains |
| 2024-07-31 | Stifel | Buy | Buy | Maintains |
| 2024-07-31 | BTIG | Buy | Buy | Maintains |
| 2024-10-30 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-10-30 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-10-30 | Truist Securities | Hold | Hold | Maintains |
| 2024-10-30 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-10-30 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2024-10-30 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-10-30 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-10-30 | BTIG | Buy | Buy | Maintains |
| 2024-10-30 | UBS | Neutral | Neutral | Maintains |
| 2024-10-30 | Baird | Outperform | Outperform | Maintains |
| 2024-10-30 | Needham | Buy | Buy | Maintains |
| 2024-10-14 | BTIG | Buy | Buy | Maintains |
| 2024-10-14 | Truist Securities | Hold | Hold | Maintains |
| 2025-01-29 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-01-29 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-01-29 | Stifel | Buy | Buy | Maintains |
| 2025-01-29 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-01-29 | Canaccord Genuity | Buy | Buy | Maintains |
| 2025-01-29 | Needham | Buy | Buy | Reiterate |
| 2025-05-02 | Roth MKM | Buy | Buy | Maintains |
| 2025-05-02 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-02-10 | Barclays | Overweight | Overweight | Maintains |
| 2025-03-21 | Needham | Buy | Buy | Reiterate |
| 2025-01-07 | RBC Capital | Outperform | Outperform | Reiterate |
| 2025-01-07 | JMP Securities | Market Perform | Market Perform | Reiterate |
| 2025-01-07 | Needham | Buy | Buy | Reiterate |
| 2025-08-04 | Truist Securities | Hold | Hold | Maintains |
| 2025-02-26 | Citigroup | Buy | Reiterate | |
| 2025-08-01 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-08-01 | Needham | Buy | Buy | Maintains |
| 2024-12-02 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2024-12-11 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-12-11 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-12-11 | Citigroup | Buy | Buy | Maintains |
| 2025-02-18 | JMP Securities | Market Perform | Market Perform | Maintains |
| 2025-05-22 | Citigroup | Buy | Buy | Maintains |
| 2025-05-05 | Truist Securities | Hold | Hold | Maintains |
| 2025-05-05 | JMP Securities | Market Perform | Market Perform | Reiterate |
| 2025-07-08 | Evercore ISI Group | Outperform | Outperform | Maintains |
